"4.4. Zvl\u00E1\u0161tn\u00ED upozorn\u011Bn\u00ED a zvl\u00E1\u0161tn\u00ED opat\u0159en\u00ED pro pou\u017Eit\u00ED"@cs . . . . . "Vibrocil nesm\u00ED b\u00FDt u\u017E\u00EDv\u00E1n nep\u0159etr\u017Eit\u011B d\u00E9le ne\u017E 1 t\u00FDden. Dlouhodob\u00E9 nebo nadm\u011Brn\u00E9 u\u017E\u00EDv\u00E1n\u00ED m\u016F\u017Ee navodit tachyfylaxi a reaktivn\u00ED (rebound) kongesci (rhinitis medicamentosa).\nStejn\u011B jako u ostatn\u00EDch m\u00EDstn\u011B aplikovan\u00FDch vazokonstrik\u010Dn\u00EDch l\u00E1tek nep\u0159ekra\u010Dujte doporu\u010Denou d\u00E1vku. Nadm\u011Brn\u00E9 u\u017E\u00EDv\u00E1n\u00ED m\u016F\u017Ee navodit syst\u00E9mov\u00E9 \u00FA\u010Dinky, zvl\u00E1\u0161t\u011B u mal\u00FDch d\u011Bt\u00ED a star\u0161\u00EDch pacient\u016F.\nU pacient\u016F s kardiovaskul\u00E1rn\u00EDm onemocn\u011Bn\u00EDm, hypertenz\u00ED, onemocn\u011Bn\u00EDm \u0161t\u00EDtn\u00E9 \u017El\u00E1zy a glaukomem s uzav\u0159en\u00FDm \u00FAhlem je doporu\u010Dena zv\u00FD\u0161en\u00E1 opatrnost.\n"@cs . "004.004" .